ILMN
Illumina, Inc.
·
$186.65
Extended — don't chase; wait for a pullback过度拉升 — 勿追高；等待回撤
Terminal终端 ↗
Illumina, Inc. · Health Care
ILMN
$186.65
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California.Illumina,Inc.是一家美国生物技术公司，总部位于加利福尼亚州圣迭戈。
Mixed profile混合特征
Large cap大盘
$29B
Engine stance引擎立场2026-07-20
Extended — don't chase; wait for a pullback过度拉升 — 勿追高；等待回撤
The bottoming setup is not yet confirmed (price still below the 10-day average) and the 3-day/weekly momentum is rolling筑底形态尚未确认（价格仍位于 10 日均线下方），且3 日/周线动量已开始掉头向下——动量在形态完成前已开始衰竭。等待价格收复 10 日均线且动量趋于稳定后再考虑建仓。
Key Statistics关键统计
Price价格
$186.65
4.0% below 52-week high低于52周高点 4.0%
Market Cap市值
$29B
Normal volume正常成交量
P/E Ratio市盈率
33.6x
28.9x sector median
Beta贝塔
0.96
Moves about 1.0x the market波动幅度约为市场的 1.0 倍
RSI (14)RSI（14）
58
Neutral zone中性区域
Next Earnings下次财报
2026-07-30 (11d)
Volatility Rank波动率分位
35th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
4.9% of float
Performance价格表现
| Period周期 | ILMN | S&P 500 | vs Index对比指数 |
|---|---|---|---|
| 1 Week近1周 | -1.9% | -1.5% | In line with the index与指数基本持平 |
| 1 Month近1月 | +17.3% | +0.6% | Beat the index by 16.7 points跑赢指数 16.7 个百分点 |
| 3 Months近3月 | +38.8% | +4.7% | Beat the index by 34.1 points跑赢指数 34.1 个百分点 |
| 6 Months近6月 | +31.8% | +7.8% | Beat the index by 24.0 points跑赢指数 24.0 个百分点 |
| Year to date年初至今 | +38.9% | +9.1% | Beat the index by 29.8 points跑赢指数 29.8 个百分点 |
| 1 Year近1年 | +90.6% | +19.4% | Beat the index by 71.2 points跑赢指数 71.2 个百分点 |
| 3 Years近3年 | +6.4% | +69.4% | Lagged the index by 63.0 points落后指数 63.0 个百分点 |
Technicals技术面
RSI (14)RSI（14）
58
Neutral zone中性区域
vs 50-day相对50日均线
+13.1% vs 50-day avg
vs 200-day相对200日均线
+38.4% vs 200-day avg
Volatility rank波动率分位
35th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$182.50
Don't chase above不追高于
$186.60
Stop止损
$159.10
Extended — wait for a pullback过度拉伸 — 等待回撤
Earnings财务业绩
11
days until next report天后公布财报
2026-07-30
Estimates being cut预期下调
Post-earnings drift: +15.3% (20d)财报后漂移：+15.3%（20日）
Earnings call transcripts — coming soon财报电话会议记录 — 即将上线
Valuation估值
| Multiple指标 | ILMN | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（历史） | 33.60x | 28.92 | 40% |
| P/B市净率 | 10.49x | 3.52 | 10% |
| P/S市销率 | 6.58x | 3.02 | 19% |
| Earnings yield盈利收益率 | 2.98% | 2.72 | 56% |
| FCF yield自由现金流收益率 | 3.26% | 3.94 | 41% |
| Shareholder yield股东收益率 | 2.60% | 1.89 | 59% |
| EV/EBITDA企业价值/EBITDA | 25.20x | 18.21 | 31% |
| P/FCF市值/自由现金流 | 30.67x | 22.42 | 32% |
Analyst price targets — coming soon分析师目标价 — 即将上线
Financials财务数据
Revenue营业收入
5yr CAGR5年复合增速: 6.0%
Earnings Per Share每股收益
5yr CAGR5年复合增速: 4.1%
Free Cash Flow自由现金流
Margins利润率
31.2%Return on Equity股本回报率
12.8%Return on Assets资产回报率
Leverage杠杆
| Net debt / EBITDA净债务/EBITDA | -1.32 |
| Current ratio流动比率 | 2.08 |
Capital Allocation资本配置
| Buybacks (TTM)回购（TTM） | $742.0M |
| Stock-based comp股权薪酬 | $275.0M |
| Share count change (1y)股数变化（1年） | -3.8% |
Piotroski皮奥特罗斯基 7/8
Altman Z阿尔特曼Z: safe (5.7)
Clean稳健
Snapshot Gauges综合指标
Valuation vs Sector估值相对行业
Expensive vs sector相对行业偏贵
Cheaper than 28% of its sector on blended multiples综合估值倍数低于行业内 28% 的公司
Beta市场敏感度
0.96×
0.21×3×
Moves about 1.0× the market波动幅度约为市场的 1.0 倍
Financial Health财务健康
7/8
Altman阿尔特曼: safe
Strong financial health财务健康状况良好
Dividend分红
—
Does not pay a dividend不派发股息
Why Is It Moving为何波动
News新闻
2 recent stories — mixed2 篇最新报道，多空参半
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Short interest changed -17.8%空头仓位变动 -17.8%
Technical技术面
ILMN daily MACD crossed downILMN 日线MACD下穿
Ownership & Smart Money持仓与聪明钱
Insider activity内部人员活动: -$0.5M net (1 buyers, 3 sellers)-$0.5M 净值（1 买家，3 卖家）
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Activity动作 | % of portfolio组合占比 | As of截至 |
|---|---|---|---|---|
| Corvex Management | A | Holding持有 | 18.8% | 2026-03-31 |
| Casdin Capital | B | trimtrim | 5.0% | 2026-03-31 |
Signal History信号历史
TURN SIGNALED
BOTTOMING
Jul 15, 2026
ILMN daily MACD crossed downILMN 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $187.15.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$187.15。
Jul 2, 2026
ILMN RSI reached overboughtILMN RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $188.68.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$188.68。
Jul 1, 2026
ILMN made a new 52-week highILMN 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $183.89.价格创出52周新高 — 全市场关注的动量/趋势极值。$183.89。
Jun 29, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jun 29, 2026
ILMN made a new 52-week highILMN 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $181.10.价格创出52周新高 — 全市场关注的动量/趋势极值。$181.10。
Jun 29, 2026
ILMN RSI reached overboughtILMN RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $181.10.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$181.10。
Jun 26, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jun 25, 2026
ILMN daily MACD crossed upILMN 日线MACD上穿
The daily MACD histogram turned positive — fast and noisy, context rather than a standalone trigger. $177.65.日线MACD柱状图转正 — 快速且嘈杂，仅作背景。$177.65。
Jun 24, 2026
ILMN made a new 52-week highILMN 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $175.09.价格创出52周新高 — 全市场关注的动量/趋势极值。$175.09。
Jun 24, 2026
ILMN StochRSI turned up from oversoldILMN StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $175.09.StochRSI重回20上方 — 下行动量趋缓的最早预警。$175.09。
Showing last 15 of显示最近15条，共 238 signals条信号
Factor Profile因子特征
Composite factor score综合因子得分: -0.17
Value价值
-0.8
Profitability盈利能力
+0.7
Quality质量
-0.0
Investment资本投入
+0.2
Shareholder payout股东回报
-0.4
Low volatility低波动
-0.6
Low market beta低市场敏感度
-0.1
Earnings quality盈利质量
-0.2
Short interest空头兴趣
+0.2
Company Profile公司档案
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California.Illumina,Inc.是一家美国生物技术公司，总部位于加利福尼亚州圣迭戈。
Demand chain:需求链： Contracted bookings (RPO) accelerating (+12% YoY to ~$1B, 0.2× revenue) — signed demand locked in ahead of recognition已签约订单（RPO）加速（同比+12%，约 $1B，覆盖营收 0.2 倍）——已锁定、尚未确认的需求
Watch items — what could change the thesis关注项 — 可能改变论点的因素
- Receivables stretch
Recent News最新动态
Cancer Biomarkers Market to Reach US$ 54.48 Billion by 2032 as Precision Oncology and Multi-Omics Adoption Accelerate
GlobeNewswire Inc.
2026-07-17
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析，覆盖所有标普500成分股。